Digipath, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
August 15, 2022 at 05:55 pm EDT
Share
Digipath, Inc. reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported sales was USD 0.682665 million compared to USD 0.764015 million a year ago. Net loss was USD 0.576733 million compared to USD 0.177214 million a year ago. Basic loss per share from continuing operations was USD 0.01. Diluted loss per share from continuing operations was USD 0.01.
For the nine months, sales was USD 1.99 million compared to USD 1.9 million a year ago. Net loss was USD 1.24 million compared to USD 0.54965 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.